St Louis, MO – According to filings with the U.S. Securities and Exchange Commission, InterShunt Technologies is raising $3,568,043.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Harlee Sorkin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About InterShunt Technologies

More than 6 Million Americans suffer from Heart Failure and for many of these patients, there are no effective solutions. As pressure builds in a failing heart, the problem makes its way upstream to the lungs making it difficult to breathe. There is evidence that when elevated pressure is relieved from the left atrium, a patient’s breathing is restored while performing normal daily activities. InterShunt is developing a proprietary transcatheter system that allows for the capture and excision of tissue from the interatrial septum. The result is a left to right atrial shunt that off-loads elevated left atrial pressure, reducing symptoms in Heart Failure patients. The mechanical system is designed for safety and ease of use and is the only interatrial shunting device that requires no implant and no energy.

To learn more about InterShunt Technologies, visit http://intershunt.com/

Contact:
Harlee Sorkin, Chief Executive Officer
314-974-4260
https://www.linkedin.com/in/harleesorkin/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved